Type 2 Diabetes Mellitus - quality prescribing strategy: improvement guide 2024 to 2027
This quality prescribing guide is intended to support clinicians across the multidisciplinary team and people with Type 2 Diabetes Mellitus (T2DM) in shared decision-making and the effective use of medicines, and offers practical advice and options for tailoring care to the needs and preferences of individuals.
Abbreviations
ACEi - angiotensin converting enzyme inhibitor
ADA - American Diabetes Association
ACR - Urine albumin to creatinine ratio
ADR - adverse drug reactions
ARB - angiotensin receptor blocker
ASCVD - atherosclerotic cardiovascular disease (e.g. angina, myocardial infarction, stroke)
BMI - Body Mass Index
BNF - British National Formulary
CFS - Clinical Frailty Scale
CKD - chronic kidney disease
CrCl - creatinine clearance
CVD - cardiovascular disease
DKA - diabetic ketoacidosis
DPP-4i - dipeptidyl peptidase-4 inhibitor, e.g., alogliptin, linagliptin, sitagliptin, saxagliptin, vildagliptin
DSMES - diabetes self-management education and support
EASD - European Association for the Study of Diabetes
eDKA - euglycaemic diabetic ketoacidosis
eGFR - estimated glomerular filtration rate
FGM - flash glucose monitor
GLP-1RA - glucagon-like peptide 1 receptor agonist, e.g., dulaglutide, exenatide, liraglutide, lixisenatide, and semaglutide
HbA1c - glycated haemoglobin
(c)HF - (chronic) heart failure
LVH - left ventricular hypertrophy
MACE - major adverse cardiovascular events
MDD - major depressive disorder
MHRA - Medicines and Healthcare products Regulatory Agency
NICE - National Institute for Health and Clinical Excellence
SG - Scottish Government
SGLT-2i - sodium-glucose co-transporter-2 inhibitor, e.g. canagliflozin, dapagliflozin, empagliflozin
SIMD - Scottish Index of Multiple Deprivation
SMG - self-monitoring glucose
SU - sulfonylurea
TZD - thiazolidinediones e.g. pioglitazone
Contact
Email: EPandT@gov.scot
There is a problem
Thanks for your feedback